Doctor profile · Federal record

Dr. Christopher Lobo, MD

Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Internal Medicine Physician · Port Charlotte, FL

  • NPI 1073571949
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 26 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
22395 Edgewater Dr
Port Charlotte, FL 339802012
(941) 766-7222
fax (941) 766-0970
Mailing address
Po Box 102222
Atlanta, GA 303682222

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
August 10, 2022
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Florida #ME89074
Medicaid
FL #275474600

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073571949. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
507,683
Distinct HCPCS
10
Medicare allowed
$7,707,955
HCPCS Description Services Patients Avg allowed
J1756 Injection, iron sucrose, 1 mg 79,100 141 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 47,940 69 $0
J9271 Injection, pembrolizumab, 1 mg 37,600 42 $54
J0185 Injection, aprepitant, 1 mg 37,570 74 $2
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 37,320 21 $0
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 34,860 28 $0
J9263 Injection, oxaliplatin, 0.5 mg 34,100 24 $0
J9299 Injection, nivolumab, 1 mg 32,720 21 $30
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 24,120 18 $48
J0897 Injection, denosumab, 1 mg 20,520 139 $23

In context: peer comparison

Among 3 peers in this city , average services per provider: 5,230. This provider delivers 97× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$876
Transactions
36
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 9 $137.04
Adaptive Biotechnologies Corporation 1 $117.82
BeiGene USA, Inc. 4 $92.90
Regeneron Healthcare Solutions, Inc. 2 $69.43
Takeda Pharmaceuticals U.S.A., Inc. 2 $66.14
Daiichi Sankyo Inc. 2 $59.03
E.R. Squibb & Sons, L.L.C. 3 $55.35
PFIZER INC. 3 $49.77
ARRAY BIOPHARMA INC 2 $47.06
Celgene Corporation 2 $40.47
Mirati Therapeutics, Inc. 2 $38.46
Eisai Inc. 1 $24.41
PharmaEssentia USA Corporation 1 $23.94
Alnylam Pharmaceuticals Inc. 1 $20.31
Merck Sharp & Dohme LLC 1 $19.43

By nature of payment

Food and Beverage
$876

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,476
Patients
627
Total drug cost
$2,189,860
Drug Type Claims Patients Total cost
Anastrozole Generic 180 53 $4,002
Ondansetron Odt (Ondansetron) Brand 133 93 $2,614
Prochlorperazine Maleate Generic 131 97 $2,776
Revlimid (Lenalidomide) Brand 121 15 $2,068,911
Eliquis (Apixaban) Brand 115 34 $98,089
Acyclovir Generic 97 36 $2,228
Hydroxyurea Generic 96 24 $2,319
Letrozole Generic 88 28 $2,106
Prednisone Generic 87 33 $609
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 86 52 $1,598

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Lobo's medical specialty?
Dr. Christopher Lobo practices Medical Oncology Physician in Port Charlotte, FL.
Where does Dr. Christopher Lobo practice?
Dr. Christopher Lobo practices at 22395 Edgewater Dr, Port Charlotte, FL 339802012. Office phone: 9417667222.
What is Dr. Christopher Lobo's NPI?
Dr. Christopher Lobo's National Provider Identifier (NPI) is 1073571949, issued by NPPES.
Does Dr. Christopher Lobo accept Medicare assignment?
Yes. Dr. Christopher Lobo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Lobo commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.